Complexity of β-lactamases among clinical Aeromonas isolates and its clinical implications

研究成果: Review article同行評審

45 引文 斯高帕斯(Scopus)

摘要

Aeromonas species, aquatic Gram-negative bacilli, distributed globally and ubiquitously in the natural environment, may be implicated in a variety of human diseases. They can produce various β-lactamases which confer resistance to a broad spectrum of β-lactams, and therefore in vitro susceptibility testing must be used to guide antimicrobial therapy. However, conventional in vitro susceptibility tests may sometimes fail to detect these β-lactamases, and hence raise a therapeutic challenge. In this review article, two chromosomally mediated β-lactamases (i.e., AmpC β-lactamases and metallo-β-lactamases) and acquired extended-spectrum β-lactamases in aeromonads are reviewed, and the clinical implications of the complexity of β-lactamases are discussed.

原文English
頁(從 - 到)398-403
頁數6
期刊Journal of Microbiology, Immunology and Infection
45
發行號6
DOIs
出版狀態Published - 2012 十二月

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology and Microbiology(all)
  • Microbiology (medical)
  • Infectious Diseases

指紋 深入研究「Complexity of β-lactamases among clinical Aeromonas isolates and its clinical implications」主題。共同形成了獨特的指紋。

引用此